Selected research
Market Structure
Global Animal Anti-Infective Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Animal Anti-Infective Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Animal Anti-Infective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Animal Anti-Infective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal Anti-Infective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Animal Anti-Infective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Animal Anti-Infective Agents include Vetoquinol, Merck, Elanco, Bayer, Zoetis, Virbac, Chanelle, Ceva Sante Animale and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Animal Anti-Infective Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Animal Anti-Infective Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Animal Anti-Infective Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Anti-Infective Agents market size, projected growth trends, production technologies, key applications, and end-use industries.
Animal Anti-Infective Agents Segment by Company
Vetoquinol
Merck
Elanco
Bayer
Zoetis
Virbac
Chanelle
Ceva Sante Animale
Boehringer Ingelheim
Bimeda Animal Health
Animal Anti-Infective Agents Segment by Type
External Use
Internal Use
Animal Anti-Infective Agents Segment by Application
Livestock
Marine Animal
Pets
Animal Anti-Infective Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Anti-Infective Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Anti-Infective Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Anti-Infective Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Animal Anti-Infective Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Anti-Infective Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Anti-Infective Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Animal Anti-Infective Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- External Use
- Internal Use
Applications
- Livestock
- Marine Animal
- Pets
Companies covered
- Vetoquinol
- Merck
- Elanco
- Bayer
- Zoetis
- Virbac
- Chanelle
- Ceva Sante Animale
- Boehringer Ingelheim
- Bimeda Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Animal Anti-Infective Agents Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Animal Anti-Infective Agents Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Animal Anti-Infective Agents Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Animal Anti-Infective Agents Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Animal Anti-Infective Agents Market Dynamics
- 2.1 Animal Anti-Infective Agents Industry Trends
- 2.2 Animal Anti-Infective Agents Industry Drivers
- 2.3 Animal Anti-Infective Agents Industry Opportunities and Challenges
- 2.4 Animal Anti-Infective Agents Industry Restraints
3 Animal Anti-Infective Agents Market by Manufacturers
- 3.1 Global Animal Anti-Infective Agents Revenue by Manufacturers (2021-2026)
- 3.2 Global Animal Anti-Infective Agents Sales by Manufacturers (2021-2026)
- 3.3 Global Animal Anti-Infective Agents Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Animal Anti-Infective Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Animal Anti-Infective Agents Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Animal Anti-Infective Agents Manufacturers, Product Type & Application
- 3.7 Global Animal Anti-Infective Agents Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Animal Anti-Infective Agents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Animal Anti-Infective Agents Players Market Share by Revenue in 2025
- 3.8.3 2025 Animal Anti-Infective Agents Tier 1, Tier 2, and Tier 3
4 Animal Anti-Infective Agents Market by Type
- 4.1 Animal Anti-Infective Agents Type Introduction
- 4.1.1 External Use
- 4.1.2 Internal Use
- 4.2 Global Animal Anti-Infective Agents Sales by Type
- 4.2.1 Global Animal Anti-Infective Agents Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Animal Anti-Infective Agents Sales by Type (2021-2032)
- 4.2.3 Global Animal Anti-Infective Agents Sales Market Share by Type (2021-2032)
- 4.3 Global Animal Anti-Infective Agents Revenue by Type
- 4.3.1 Global Animal Anti-Infective Agents Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Animal Anti-Infective Agents Revenue by Type (2021-2032)
- 4.3.3 Global Animal Anti-Infective Agents Revenue Market Share by Type (2021-2032)
5 Animal Anti-Infective Agents Market by Application
- 5.1 Animal Anti-Infective Agents Application Introduction
- 5.1.1 Livestock
- 5.1.2 Marine Animal
- 5.1.3 Pets
- 5.2 Global Animal Anti-Infective Agents Sales by Application
- 5.2.1 Global Animal Anti-Infective Agents Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Animal Anti-Infective Agents Sales by Application (2021-2032)
- 5.2.3 Global Animal Anti-Infective Agents Sales Market Share by Application (2021-2032)
- 5.3 Global Animal Anti-Infective Agents Revenue by Application
- 5.3.1 Global Animal Anti-Infective Agents Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Animal Anti-Infective Agents Revenue by Application (2021-2032)
- 5.3.3 Global Animal Anti-Infective Agents Revenue Market Share by Application (2021-2032)
6 Global Animal Anti-Infective Agents Sales by Region
- 6.1 Global Animal Anti-Infective Agents Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Animal Anti-Infective Agents Sales by Region (2021-2032)
- 6.2.1 Global Animal Anti-Infective Agents Sales by Region (2021-2026)
- 6.2.2 Global Animal Anti-Infective Agents Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Animal Anti-Infective Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Animal Anti-Infective Agents Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Animal Anti-Infective Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Animal Anti-Infective Agents Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Animal Anti-Infective Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Animal Anti-Infective Agents Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Animal Anti-Infective Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Animal Anti-Infective Agents Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Animal Anti-Infective Agents Revenue by Region
- 7.1 Global Animal Anti-Infective Agents Revenue by Region
- 7.1.1 Global Animal Anti-Infective Agents Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Animal Anti-Infective Agents Revenue by Region (2021-2026)
- 7.1.3 Global Animal Anti-Infective Agents Revenue by Region (2027-2032)
- 7.1.4 Global Animal Anti-Infective Agents Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Animal Anti-Infective Agents Revenue (2021-2032)
- 7.2.2 North America Animal Anti-Infective Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Animal Anti-Infective Agents Revenue (2021-2032)
- 7.3.2 Europe Animal Anti-Infective Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Animal Anti-Infective Agents Revenue (2021-2032)
- 7.4.2 Asia-Pacific Animal Anti-Infective Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Animal Anti-Infective Agents Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Animal Anti-Infective Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Vetoquinol
- 8.1.1 Vetoquinol Company Information
- 8.1.2 Vetoquinol Business Overview
- 8.1.3 Vetoquinol Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Vetoquinol Animal Anti-Infective Agents Product Portfolio
- 8.1.5 Vetoquinol Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Animal Anti-Infective Agents Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 Elanco
- 8.3.1 Elanco Company Information
- 8.3.2 Elanco Business Overview
- 8.3.3 Elanco Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Elanco Animal Anti-Infective Agents Product Portfolio
- 8.3.5 Elanco Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer Animal Anti-Infective Agents Product Portfolio
- 8.4.5 Bayer Recent Developments
- 8.5 Zoetis
- 8.5.1 Zoetis Company Information
- 8.5.2 Zoetis Business Overview
- 8.5.3 Zoetis Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zoetis Animal Anti-Infective Agents Product Portfolio
- 8.5.5 Zoetis Recent Developments
- 8.6 Virbac
- 8.6.1 Virbac Company Information
- 8.6.2 Virbac Business Overview
- 8.6.3 Virbac Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Virbac Animal Anti-Infective Agents Product Portfolio
- 8.6.5 Virbac Recent Developments
- 8.7 Chanelle
- 8.7.1 Chanelle Company Information
- 8.7.2 Chanelle Business Overview
- 8.7.3 Chanelle Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Chanelle Animal Anti-Infective Agents Product Portfolio
- 8.7.5 Chanelle Recent Developments
- 8.8 Ceva Sante Animale
- 8.8.1 Ceva Sante Animale Company Information
- 8.8.2 Ceva Sante Animale Business Overview
- 8.8.3 Ceva Sante Animale Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ceva Sante Animale Animal Anti-Infective Agents Product Portfolio
- 8.8.5 Ceva Sante Animale Recent Developments
- 8.9 Boehringer Ingelheim
- 8.9.1 Boehringer Ingelheim Company Information
- 8.9.2 Boehringer Ingelheim Business Overview
- 8.9.3 Boehringer Ingelheim Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Boehringer Ingelheim Animal Anti-Infective Agents Product Portfolio
- 8.9.5 Boehringer Ingelheim Recent Developments
- 8.10 Bimeda Animal Health
- 8.10.1 Bimeda Animal Health Company Information
- 8.10.2 Bimeda Animal Health Business Overview
- 8.10.3 Bimeda Animal Health Animal Anti-Infective Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bimeda Animal Health Animal Anti-Infective Agents Product Portfolio
- 8.10.5 Bimeda Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Animal Anti-Infective Agents Value Chain Analysis
- 9.1.1 Animal Anti-Infective Agents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Animal Anti-Infective Agents Production Mode & Process
- 9.2 Animal Anti-Infective Agents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Animal Anti-Infective Agents Distributors
- 9.2.3 Animal Anti-Infective Agents Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst